All of this highlights the importance of a long-term treatment plan
Market Size and Context The CPHA piece reports that about one-third of Canadian adults now live with obesity, and that the condition is associated with over $27 billion in economic costs in Canada including healthcare, productivity losses, and premature death
Their use in these populations has been associated with hemoglobin A1c reduction, significant weight loss, and a decrease in long-term microvascular and macrovascular complications ( This mini-review discusses clinical studies evaluating adjuvant treatment with GLP-1RA in patients with T1D as an opportunity to improve glycemic control, achieve weight loss, and decrease total daily insulin (TDI) requirements in these patients
Lifetime access + free future updates included
They reported mild gastrointestinal symptoms and no substantial changes in disease activity scores (104, 105)
This is a promising first step, and it could pave the way for Medicare to eventually cover these drugs as well